PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'John Billington, JD, MPH, is Director, Science Policy, and Emmanuel Hanon, PhD, DVM, is Senior Vice President, Head of R&D; both at GSK Vaccines, Wavre, Belgium.\', \'Isabelle Deschamps, PhD, is Head of Global Vaccine Public Affairs; and John W. Shiver, PhD, is Senior Vice President R&D; both with Sanofi Pasteur, Lyon, France.\', \'Stanley C. Erck, MBA, is President and Chief Executive Officer, Novavax, Gaithersburg, MD.\', \'Julie L. Gerberding, MD, MPH, is Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health; and Julia A. Spencer, PhD, is Associate Vice President, Global Public Policy; both with Merck & Co., Inc., Kenilworth, NJ.\', \'Sabrina Ivol is Senior Specialist, Policy; and Johan Van Hoof, MD, is Managing Director; both with Janssen Vaccines & Prevention BV, Janssen Pharmaceuticals R&D, Leiden, Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1089/hs.2020.0043
?:hasPublicationType
?:journal
  • Health security
is ?:pmid of
?:pmid
?:pmid
  • 32348165
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.739
?:rankingScore_hIndex
  • 32
?:title
  • Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32348165>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32348165>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all